2-Arylmethyl-1, 4-benzoquinones. II. Novel Inhibitors of Platelet Aggregation : Synthesis and Pharmacological Evaluation
Two new series of 2-arylmethyl-1, 4-benzoquinones (2 and 3) were synthesized for evaluation of their pharmacological activities. These compounds showed significant inhibition of platelet aggregation and some of them possessed a protective effect against endothelial cell injury. Structure-activity re...
Saved in:
Published in | Chemical & pharmaceutical bulletin Vol. 45; no. 4; pp. 668 - 674 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Tokyo
The Pharmaceutical Society of Japan
1997
Maruzen |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Two new series of 2-arylmethyl-1, 4-benzoquinones (2 and 3) were synthesized for evaluation of their pharmacological activities. These compounds showed significant inhibition of platelet aggregation and some of them possessed a protective effect against endothelial cell injury. Structure-activity relationship studies indicated that 2b, 2d and 3b are potent inhibitors of platelet aggregation induced by arachidonic acid (AA) with an IC50 in the range of 1-10 μg/ml. Among them, 3b showed a significant inhibitory activity against endothelial cell injury caused by hydrogen peroxide (H2O2) at 1 μM. |
---|---|
AbstractList | Two new series of 2-arylmethyl-1,4-benzoquinones (2 and 3) were synthesized for evaluation of their pharmacological activities. These compounds showed significant inhibition of platelet aggregation and some of them possessed a protective against endothelial cell injury. Structure-activity relationship studies indicated that 2b, 2d and 3b are potent inhibitors of platelet aggregation induced by arachidonic acid (AA) with an IC50 in the range of 1-10 micrograms/ml. Among them, 3b showed a significant inhibitory activity against endothelial cell injury caused by hydrogen peroxide (H2O2) at 1 microM. Two new series of 2-arylmethyl-1, 4-benzoquinones (2 and 3) were synthesized for evaluation of their pharmacological activities. These compounds showed significant inhibition of platelet aggregation and some of them possessed a protective effect against endothelial cell injury. Structure-activity relationship studies indicated that 2b, 2d and 3b are potent inhibitors of platelet aggregation induced by arachidonic acid (AA) with an IC50 in the range of 1-10 μg/ml. Among them, 3b showed a significant inhibitory activity against endothelial cell injury caused by hydrogen peroxide (H2O2) at 1 μM. |
Author | MIYAZAKI, Tomoko MIYANO, Seiji SUZUKI, Kenji SATOH, Fumio SUMOTO, Kunihiro OGINO, Ryoko TATSUOKA, Toshio ISHIHARA, Takafumi |
Author_xml | – sequence: 1 fullname: SUZUKI, Kenji – sequence: 2 fullname: TATSUOKA, Toshio – sequence: 3 fullname: ISHIHARA, Takafumi – sequence: 4 fullname: OGINO, Ryoko – sequence: 5 fullname: MIYAZAKI, Tomoko – sequence: 6 fullname: SATOH, Fumio – sequence: 7 fullname: MIYANO, Seiji – sequence: 8 fullname: SUMOTO, Kunihiro |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2676116$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/9145502$$D View this record in MEDLINE/PubMed |
BookMark | eNpFkM9v0zAUxy00NLrBhTuSD4gDIsG_E-9WVduoNMEk4Bw5zkvqyXGKnU6Uvx6XVuXy3uH70fvqfa7QRZgCIPSWkpIyUX-227YUslSqfoEWlIuqkIzxC7QghOiCccVfoauUnghhklT8El1qKqQkbIF-s2IZ936EebP3Bf2ERdFC-DP92rlDSSrxel3ir9MzeLwOG9e6eYoJTz1-9GYGDzNeDkOEwcxuCvgGf9-HeQPJJWxChx83Jo7GTn4anDUe3z4bv_uHvkYve-MTvDnta_Tz7vbH6kvx8O1-vVo-FFbUui6YNr1lRvWi5ZL10EktlFS6FZwJJjRIVStR0661lTGyo4xw0G3f5bhTIPk1-nC8u435KUhzM7pkwXsTYNqlptLZimZ1Bj8eQRunlCL0zTa60cR9Q0lz0NxkzY2QTdac4Xenq7t2hO6Mnrzm_P0pNyn_3UcTrEtnjKlKUaoytjpiT2k2A5xzE2dnPRwaqZb1oVUcRy7_n2a5DQT-F32Qnm0 |
CODEN | CPBTAL |
CitedBy_id | crossref_primary_10_1016_j_bmcl_2006_03_074 crossref_primary_10_1002_chin_199743096 |
ContentType | Journal Article |
Copyright | The Pharmaceutical Society of Japan 1997 INIST-CNRS |
Copyright_xml | – notice: The Pharmaceutical Society of Japan – notice: 1997 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1248/cpb.45.668 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1347-5223 |
EndPage | 674 |
ExternalDocumentID | 10_1248_cpb_45_668 9145502 2676116 article_cpb1958_45_4_45_4_668_article_char_en |
Genre | Journal Article |
GroupedDBID | --- .55 2WC 53G 5GY 6J9 AAUGY ABTAH ACGFO ACIWK ACPRK ADBBV AENEX AFRAH AI. ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK DU5 EBS EJD F5P GX1 HH5 JSF JSH KQ8 L7B OK1 P2P RJT RZJ TKC TR2 VH1 X7M ZGI ZY4 .GJ 29B 3O- AABQG ABFLS ADGIM BKOMP E3Z IQODW JMI MOJWN X7J XSB ZE2 CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c4898-29afc2a6f4b352fed5946569b4324249e5686481dbc7aa5d1203e9bfd324d6e53 |
ISSN | 0009-2363 |
IngestDate | Fri Aug 16 00:45:02 EDT 2024 Fri Aug 23 01:31:04 EDT 2024 Sat Sep 28 08:33:28 EDT 2024 Fri Nov 25 16:31:38 EST 2022 Thu Aug 17 20:25:56 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Endothelial cell Enzyme Quinone Enzyme inhibitor Rabbit Anticoagulant Lagomorpha Oxygen heterocycle Morpholine derivatives In vitro Antiplatelet agent L-Lactate dehydrogenase Vertebrata Mammalia Cytoprotector Structure activity relation Animal Bicyclic compound Carboxamide Benzenic compound Aromatic compound Oxidoreductases Benzofuran derivatives Chemical synthesis |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4898-29afc2a6f4b352fed5946569b4324249e5686481dbc7aa5d1203e9bfd324d6e53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/cpb1958/45/4/45_4_668/_article/-char/en |
PMID | 9145502 |
PQID | 79002928 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_79002928 crossref_primary_10_1248_cpb_45_668 pubmed_primary_9145502 pascalfrancis_primary_2676116 jstage_primary_article_cpb1958_45_4_45_4_668_article_char_en |
PublicationCentury | 1900 |
PublicationDate | 1997-00-00 |
PublicationDateYYYYMMDD | 1997-01-01 |
PublicationDate_xml | – year: 1997 text: 1997-00-00 |
PublicationDecade | 1990 |
PublicationPlace | Tokyo |
PublicationPlace_xml | – name: Tokyo – name: Japan |
PublicationTitle | Chemical & pharmaceutical bulletin |
PublicationTitleAlternate | Chem. Pharm. Bull. |
PublicationYear | 1997 |
Publisher | The Pharmaceutical Society of Japan Maruzen |
Publisher_xml | – name: The Pharmaceutical Society of Japan – name: Maruzen |
References | 5) Goto G., Okamoto K., Okutani T., Imada I., Chem. Pharm. Bull., 33, 4422 (1985). 9) a) Abe M., Morita I., Murota S., PG LT Essent. Fatty Acids, 34, 69 (1988 2) Hamberg M., Svensson J., Samuelsson B., Proc. Natl. Acad. Sci. U.S.A., 72, 2994 (1975). 6) Smith W.E., J. Org. Chem., 37, 3972 (1972). 3) Shiraishi M., Kato K., Terao S., Ashida Y., Terashita Z., Kito G., J. Med. Chem., 32, 2214 (1989). 4) Syper L., Kloc K., Mlochowski J., Szulc Z., Synthesis, 1979, 521. 1) Suzuki K., Tatsuoka T., Murakami T., Ishihara T., Aisaka K., Inoue T., Ogino R., Kuroki M., Miyazaki T., Satoh F., Miyano S., Sumoto K., Chem. Pharm. Bull., 44, 139 (1996). 7) Johnson R.A., Nidy E.G., Aiken J.W., Crittenden N.J., Gorman R.R., J. Med. Chem., 29, 1461 (1986). b) Whorton A.R., Montogomery M.E., Kent R.S., J. Clin. Invest., 76, 295 (1985). 8) Born G.V.R., Nature (London), 194, 927 (1962). |
References_xml | |
SSID | ssj0025073 |
Score | 1.5411773 |
Snippet | Two new series of 2-arylmethyl-1, 4-benzoquinones (2 and 3) were synthesized for evaluation of their pharmacological activities. These compounds showed... Two new series of 2-arylmethyl-1,4-benzoquinones (2 and 3) were synthesized for evaluation of their pharmacological activities. These compounds showed... |
SourceID | proquest crossref pubmed pascalfrancis jstage |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 668 |
SubjectTerms | 1, 4-benzoquinone Animals anti-platelet aggregation arachidonic acid Arachidonic Acid - pharmacology Benzoquinones - chemistry Benzoquinones - pharmacology Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system endothelial cell Endothelium, Vascular - drug effects Endothelium, Vascular - metabolism hydrogen peroxide Hydrogen Peroxide - metabolism Male Medical sciences Pharmacology. Drug treatments Platelet Aggregation - drug effects Platelet Aggregation Inhibitors - chemical synthesis Rabbits Structure-Activity Relationship |
Title | 2-Arylmethyl-1, 4-benzoquinones. II. Novel Inhibitors of Platelet Aggregation : Synthesis and Pharmacological Evaluation |
URI | https://www.jstage.jst.go.jp/article/cpb1958/45/4/45_4_668/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/9145502 https://search.proquest.com/docview/79002928 |
Volume | 45 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Chemical and Pharmaceutical Bulletin, 1997/04/15, Vol.45(4), pp.668-674 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLVg8ICEEF8TBQaWQHtpUxrXcRLEyzRtWmF0Q0qlvkV2YndlU1st6aT213NvnCbNAPHxYlWObTk5pzfXse-5hLx3mUgDg9nLEtc43E-kI02QODphYDGV7qcBRiN_HYqTEf889sb1gcwiuiRX3WT9y7iS_0EV6gBXjJL9B2SrQaECfgO-UALCUP4Vxsw5uF5dYRLo1ZUDJumQO0rP1mDrpzPU4O-2B4Nuezi_0aiscTFV0yK3zrxIHp3DCydvywksuCfVEY9sNQOPEEVKCgGBWte6wLKWBt_2aSvNAWRR2WXzjVxtq3sXe0_r5WUzAXYk82w5v5SNE9uD7GKKUtKNyrPJtEgUXh5yTMvgPb9heUOH9UtjVlpeKyRZMoxvmVFhU-2Ub2Rh8_j8ZOwZxwCGZKG63OtWXbYVtYdn8fHo9DSOjsbRXXKPgTHCY59fvlU7TeAB-lW2PZxfKWELY3-oR244Lfe_g9-OggwPFzKDR2lsBpTfL1EKVyV6TB6Vawx6YAnzhNzRs6dk_9wis-rQqI65yzp0n57XMK-ekZsmqzq3OUWBU7TgFK05ReeGbjhFtzj1kVaMosAoeotRtGbUczI6PooOT5wyO4eT8CDE0B1pEiaF4QqceKNTL0TtvVChxiMs6rUnAsFhOaQSX0ovdVmvr0NlUricCu31d8kOzvsFoT1wSo2ngDAoHKJV4GnusyDp9YwwieAt8m7z-OOFFWGJcfEKIMUAUsy9GEBqkU8WmapN-cfENqiphO24LaB5fRXuHKxJi-w18KxGYcIXrita5O0G3xhMMO6ryZmeL7PYD3Fvm8EEdi3sVdewSAPAXv6x6yvywOoi47e912Qnv17qPfB2c_WmoOsPFHCyGw |
link.rule.ids | 315,783,787,4031,27935,27936,27937 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2-Arylmethyl-1%2C4-benzoquinones.+II.+Novel+inhibitors+of+platelet+aggregation%3A+synthesis+and+pharmacological+evaluation&rft.jtitle=Chemical+%26+pharmaceutical+bulletin&rft.au=Suzuki%2C+K&rft.au=Tatsuoka%2C+T&rft.au=Ishihara%2C+T&rft.au=Ogino%2C+R&rft.date=1997&rft.issn=0009-2363&rft.volume=45&rft.issue=4&rft.spage=668&rft.epage=674&rft_id=info:doi/10.1248%2Fcpb.45.668&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-2363&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-2363&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-2363&client=summon |